Standout Papers
- Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition (2000)
- Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression (2001)
- Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex (1999)
- Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: The role of the chromatin structure and AP-1 composition (2000)
Citation Impact
Citing Papers
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.
2003
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
2004 StandoutNobel
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
The chemopreventive compound curcumin is an efficient inhibitor of Epstein‐Barr virus BZLF1 transcription in Raji DR‐LUC cells*
2002
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Classification of papillomaviruses
2004 StandoutNobel
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
1999 StandoutNobel
Down-regulation of p21 contributes to apoptosis induced by HPV E6 in human mammary epithelial cells
2005
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Papillomaviruses—to vaccination and beyond
2008 StandoutNobel
The Fos family of transcription factors and their role in tumourigenesis
2005
Viruses in human cancers
1999 StandoutNobel
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis
2004
Human papillomaviruses in non-melanoma skin cancer
1999
The Epigenomics of Cancer
2007 Standout
The molecular biology of head and neck cancer
2010 Standout
Epigenetics in Cancer
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Cancer genes and the pathways they control
2004 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Viruses in human cancers
1999 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
2018 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1
2005
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun
2008
Targeting apoptosis in cancer therapy
2020 Standout
The pathobiology of mucositis
2004 Standout
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
2005
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Diindolylmethane Alters Gene Expression in Human Keratinocytes In Vitro
2002
Papillomaviruses in Human Cancers
1999 StandoutNobel
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Enhancement of Radiation Sensitivity of Human Squamous Carcinoma Cells by Histone Deacetylase Inhibitors
2004
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Oncogenic DNA viruses
2001 StandoutNobel
Function and regulation of AP-1 subunits in skin physiology and pathology
2001
Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability
2005
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
2001 StandoutNobel
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
2003
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
The pros, cons, and many unknowns of probiotics
2019 Standout
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins
2006
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases
2013
Regulation Mechanisms and Signaling Pathways of Autophagy
2009 Standout
Human Papillomavirus and Cervical Cancer
2003 Standout
Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification
2007
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Apoptotic and autophagic cell death induced by histone deacetylase inhibitors
2004
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
2003
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Works of Patrick Finzer being referenced
Growth Arrest of HPV-Positive Cells after Histone Deacetylase Inhibition Is Independent of E6/E7 Oncogene Expression
2002
Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: The role of the chromatin structure and AP-1 composition
2000 StandoutNobel
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
2002
HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F–p73 pathway
2004
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
2001 StandoutNobel
Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition
2000 StandoutNobel
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel